When comparing TOR1B expression among the four breast cancer subtypes, no significant difference was found between Luminal A and Her2-enriched subtypes, while differences in TOR1B expression levels were observed among the remaining subtypes, indicating significant variability in TOR1B expression across different breast cancer classifications (Fig. 1B, Supplementary Material 2). The gene discussed is ERBB2; the disease is breast carcinoma.